Pro: Heterotopic TTVR Technologies Are Evolving, thus Their Indications Will Expand!
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Equity/Stock(s)/Options - Center Line Biomedical; VahatiCor
- Consultant Fee/Honoraria/Speaker's Bureau - P+F Products + Features GmbH; Abbott; Alleviant Medical; Medtronic; Anteris